162 filings
Page 5 of 9
8-K
bzt li59ndww
29 Oct 20
Moderna Reports Third Quarter 2020 Financial Results and Provides Business Updates
7:07am
8-K
kvkwxt3cnlsl0
18 Sep 20
Regulation FD Disclosure
10:40am
8-K
hixpxz8y9wikzw56
12 Aug 20
Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses of mRNA
6:06am
8-K
6wy8kf vzpxzcmsezlc
5 Aug 20
Moderna Reports Second Quarter 2020 Financial Results and Provides Business Updates
7:22am
8-K
ub628ih1swaqy1
31 Jul 20
Moderna Announces Resignation of Dr. Elizabeth Nabel from Board of Directors
12:00am
8-K
hnvt41u3fhilg2z2l4
29 Jul 20
Moderna Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical
12:00am
8-K
5d6m0bfeh23vd
27 Jul 20
Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19
8:53am
8-K
jqssk fw06hjrt
15 Jul 20
Other Events
7:32am
8-K
0asaoun8 dcgy3
2 Jul 20
Regulation FD Disclosure
5:02pm
8-K
4li5c w2v1tn9o9x
2 Jul 20
Departure of Directors or Certain Officers
4:31pm
8-K
sp1lmh
12 Jun 20
Regulation FD Disclosure
9:20am
8-K/A
zgtxqnnrpdn3aq3
9 Jun 20
Departure of Directors or Certain Officers
5:06pm
8-K
qwbwive
4 Jun 20
David Meline Joins Moderna as Chief Financial Officer
4:06pm
8-K
cn9dd7 qarbi68
20 May 20
Moderna Announces Pricing of Public Offering of Shares of Common Stock
5:15pm
424B5
5qwplxoj6y ab3o
20 May 20
Prospectus supplement for primary offering
5:11pm
S-3ASR
dz2b hffi18787r
18 May 20
Automatic shelf registration
4:13pm
8-K
2xcnd4t
18 May 20
Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
7:37am
8-K
lpe3das k73r26
15 May 20
Moderna Congratulates Dr. Moncef Slaoui on His Appointment to Oversee the White House’s
2:42pm